<DOC>
	<DOCNO>NCT00225706</DOCNO>
	<brief_summary>The primary objective study Caldolor administer febrile hospitalize pediatric patient every 6 hour 24 hour determine clinical equivalence single dose Caldolor compare acetaminophen ( paracetamol ; APAP ) treatment fever measure AUC Tº within first 6 hour treatment ( compare target temperature 98.6ºF [ 37.0ºC ] ) .</brief_summary>
	<brief_title>A Study Caldolor Hospitalized Febrile Pediatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1 . Be hospitalize 2 . Be 6 month 17 year age , inclusive 3 . Have new ( chronic , within last 7 day ) onset fever , document temperature great equal 101.0ºF ( 38.3ºC ) ( The prefer method temperature measurement core . The route temperature measurement use immediately randomization use immediately dosing temperature measurement Treatment Period . ) 4 . Have write informed consent provide legal parent , guardian , authorized agent , agree abide study restriction return require assessment ( Where appropriate , participant appropriate intellectual maturity personally provide write informed assent ; age assent may determine Institutional Review Boards ( IRBs ) Independent Ethics Committees ( IECs ) consistent local legal requirement . ) 1 . Have inadequate intravenous access 2 . Have receive antipyretic drug therapy within 8 hour dose 3 . Be pregnant nursing 4 . Have history allergy hypersensitivity NSAIDs , aspirin , APAP , component Caldolor APAP . 5 . Have history severe head trauma require current hospitalization , intracranial surgery stroke within previous 30 day , history intracerebral arteriovenous malformation , cerebral aneurysm , central nervous system mass lesion 6 . Have history febrile convulsion sibling history febrile convulsion 7 . Have history congenital bleeding diatheses ( e.g. , hemophilia ) active clinically significant bleeding , underlie platelet dysfunction , include ( limited ) idiopathic thrombocytopenic purpura , disseminate intravascular coagulation , congenital platelet dysfunction 8 . Have gastrointestinal bleeding require medical intervention within previous 6 week , unless definitive surgery perform 9 . Have platelet count le 30,000/mm3 10 . Be receive full dose anticoagulation therapy ( Prophylaxis subcutaneous heparin acceptable . ) 11 . Have fever secondary blood drug reaction 12 . Have expect life span le 14 day imminent withdrawal life support severity illness 13 . Be receive ongoing imminent treatment corticosteroid 14 . Have neurogenic fever 15 . Be dialysis , oliguria calculate creatinine clearance le 70 mL/min ( calculate use Schwartz formula ) , impaired renal function , receive nephrotoxic drug , expect unable tolerate extra fluid require administration CTM 16 . Have major surgery within past 12 hour , unless adequate hemostasis achieve 17 . Have receive another investigational drug within past 30 day 18 . Be otherwise unsuitable study , opinion Investigator</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>